Steve Jobs Cancer

The bad news is that pancreatic neuroendocrine tumors are growing more prevalent, but

they are also becoming more treatable (the good news).

Steve Jobs fared better than many other people who were diagnosed with pancreatic

cancer. On October 5, 2011, the visionary co-founder of Apple died, almost precisely eight years

after his cancer was diagnosed by chance on a CT scan of his kidneys (the pancreas is near the

left kidney). According to Jobs ' best-selling memoir, his urologist had advised him to have the

scan because of kidney stones he'd had many years before, which was written soon after his

death.

However, some cancer experts believe Jobs didn't have pancreatic cancer, at least not in

the traditional sense. He was diagnosed with a neuroendocrine tumor, which is an unusual form

of cancer. While neuroendocrine tumors can grow in the pancreas, two-thirds of all

neuroendocrine tumors develop elsewhere in the body. Neuroendocrine tumors and pancreatic

cancer are two distinct forms of cancers that originate from different cells, have different effects,

and need other treatments.

Sunitinib (Sutent) and everolimus (Afinitor), which disrupt molecular-level signaling

within cancerous cells and act in a far more focused manner than traditional chemotherapy, were

authorized by the FDA. In 2011 for pancreatic neuroendocrine tumors occurred due to low

amounts of antigen in his body. Hemophilia cancer researchers see sunitinib, everolimus, and

similar therapies as the next generation of cancer treatments. The pancreas, which is oblong and

tapered at one end, calls to mind a tiny eyeless squid with no long tentacles in front and no fin in

back. The division of the body into a head, body, and tail encourages animal imagery.
 Since the pancreas is so similar to and intertwined with so many other organisms,

pancreatic cancer is hazardous. Branches of main arteries and veins supply the liver. The head is

grooved to accommodate the typical bile duct, which connects the liver to the small intestine,

and it seems to be nuzzling the small intestine. The body is pressed against the aorta, and the tail

appears to be encroaching on the spleen and left kidney's room. When pancreatic neuroendocrine

tumors spread, the liver is usually the first where they go. Surgical removal of the cancer is

possible, depending on the position and duration. If surgery isn't an option, several patients

undergo a hepatic arterial embolization, which involves blocking one of the liver's major arteries

emerging from Kaposis Sarcoma agents. Since cancer may not go anywhere, it may shrink as a

result of the lack of blood.

Jobs received a liver transplant in 2009 after his disease spread to his liver. "Extremely

investigational," according to Dr. Kulke, is liver transplantation for patients with pancreatic

neuroendocrine tumors. He found out that a transplant would not prevent the disease from

returning due to less lymphocyte cells, either in the fresh liver or anywhere in the body. Of

default, Jobs' cancer returned, and he died. Jobs' diseased liver, according to the biography, was

full of cancer when it was extracted, indicating that cancer most possibly progressed beyond the

pancreas and liver. According to the biography, the peritoneum, the membrane that lines the

abdominal cavity, was also found to have suggestive spots.

Jobs' incidental finding on a CT scan has become more common (of all cancers, not just

pancreatic neuroendocrine tumors), so more detection in this age of high-resolution medical

imaging could account for some of the rises. However, the possibility of an actual increase in

these tumors cannot be ruled out.